Cell Detect
CellDetect® is a Trademark of Zetiq Technologies, a fully-owned subsidiary of Micromedic. Micromedic Technologies Ltd. (TASE: MCTC) is engaged in the development and commercialization of unique solutions addressing substantial unmet needs in the field of cancer diagnostics, primarily early cancer detection.
Micromedic has initiated the process of engaging partners for the commercialization of the CellDetect® Bladder Cancer kit in Europe and countries adopting the CE regulatory standard. Selective European medical centers have already started using the product.
